The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Pharmacist Care of Patients With Heart Failure<subtitle>A Systematic Review of Randomized Trials</subtitle>
Abstract
BACKGROUND: While the role of multidisciplinary teams in the treatment of patients with heart failure (HF) is well established, there is less evidence to characterize the role of individual team members. To clarify the role of pharmacists in the care of patients with HF, we performed a systematic review evaluating the effect of pharmacist care on patient outcomes in HF. METHODS: We searched PubMed, MEDLINE, EMBASE, International Pharmaceutical Abstracts, Web of Science, Scopus, Dissertation Abstracts, CINAHL, Pascal, and Cochrane Central Register of Controlled Trials for controlled studies from database inception to August 2007. We included randomized controlled trials that evaluated the impact of pharmacist care activities on patients with HF (in both inpatient and outpatient settings). Summary odds ratios (ORs) with 95% confidence intervals (CIs) were calculated using a random-effects model for rates of all-cause hospitalization, HF hospitalization, and mortality. RESULTS: A total of 12 randomized controlled trials (2060 patients) were identified. Extent of pharmacist involvement varied among studies, and each study intervention was categorized as pharmacist-directed care or pharmacist collaborative care using a priori definitions and feedback from primary study authors. Pharmacist care was associated with significant reductions in the rate of all-cause hospitalizations (11 studies [2026 patients]) (OR, 0.71; 95% CI, 0.54-0.94) and HF hospitalizations (11 studies [1977 patients]) (OR, 0.69; 95% CI, 0.51-0.94),and a nonsignificant reduction in mortality (12 studies [2060 patients])(OR, 0.84; 95% CI, 0.61-1.15). Pharmacist collaborative care led to greater reductions in the rate of HF hospitalizations (OR, 0.42; 95%CI, 0.24-0.74) than pharmacist-directed care (OR, 0.89; 95% CI, 0.68-1.17). CONCLUSIONS: Pharmacist care in the treatment of patients with HF greatly reduces the risk of all-cause and HF hospitalizations. Since hospitalizations associated with HF are a major public health problem, the incorporation of pharmacists into HF care teams should be strongly considered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
Song, F., Altman, D. G., Glenny, A.-M., & Deeks, J. J. (2003) · BMJ · doi:10.1136/bmj.326.7387.472 · Cited by 943
Assessing the influence of a single study in the meta-anyalysis estimate
Tobı́as, A. (1999) · Stata technical bulletin · Cited by 499
Pharmacist Intervention to Improve Medication Adherence in Heart Failure: A Randomized Trial
Murray, M. D., Young, J., Hoke, S., Tu, W., Weiner, M., Morrow, D., Stroupe, K. T., Wu, J., Clark, D., Smith, F., et al. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-10-200705150-00005 · Cited by 470
Gattis, W. A., Hasselblad, V., Whellan, D. J., & O'Connor, C. M. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.16.1939 · Cited by 462
Stewart, S., Pearson, S., & Horowitz, J. D. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.10.1067 · Cited by 461
Systematic review of multidisciplinary interventions in heart failure
Holland, R., Battersby, J., Harvey, I., Lenaghan, E., Smith, J., & Hay, L. (2005) · Heart · doi:10.1136/hrt.2004.048389 · Cited by 398
Acute Precipitants of Congestive Heart Failure Exacerbations
Tsuyuki, R. T., McKelvie, R. S., Arnold, J. M. O., Avezum, Jr., Barretto, A. C. P., Carvalho, A. C. C., Isaac, D. L., Kitching, A. D., Piegas, L. S., Teo, K. K., et al. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.19.2337 · Cited by 336
Bouvy, M. L., Heerdink, E. R., Urquhart, J., Grobbee, D. E., Hoe, A. W., & Leufkens, H. G. M. (2003) · Journal of Cardiac Failure · doi:10.1054/s1071-9164(03)00130-1 · Cited by 195
López Cabezas, C., Falces Salvador, C., Cubí Quadrada, D., Arnau Bartés, A., Ylla Boré, M., Muro Perea, N., & Homs Peipoch, E. (2006) · Farmacia Hospitalaria · doi:10.1016/s1130-6343(06)74004-1 · Cited by 182
MCALISTER, F., STEWART, S., FERRUA, S., & MCMURRAY, J. (2004) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(04)01123-4 · Cited by 180
Koelling, T. M., Chen, R. S., Lubwama, R. N., L'Italien, G. J., & Eagle, K. A. (2004) · American Heart Journal · doi:10.1016/j.ahj.2003.07.021 · Cited by 180
Pharmaceutical Care of Patients with Congestive Heart Failure: Interventions and Outcomes
Varma, S., McElnay, J. C., Hughes, C. M., Passmore, A. P., & Varma, M. (1999) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.19.10.860.31565 · Cited by 178
Holland, R., Brooksby, I., Lenaghan, E., Ashton, K., Hay, L., Smith, R., Shepstone, L., Lipp, A., Daly, C., Howe, A., et al. (2007) · BMJ · doi:10.1136/bmj.39164.568183.ae · Cited by 175
Arnold, J. M. O., Howlett, J. G., Dorian, P., Ducharme, A., Giannetti, N., Haddad, H. A., Heckman, G. A., Ignaszewski, A. P., Isaac, D., Jong, P., et al. (2007) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(07)70211-8 · Cited by 167
A multicenter disease management program for hospitalized patients with heart failure
Tsuyuki, R. T., Fradette, M., Johnson, J. A., Bungard, T. J., Eurich, D. T., Ashton, T., Gordon, W., Ikuta, R. M., Kornder, J. M., Mackay, E., et al. (2004) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2004.02.005 · Cited by 132
Pharmaceutical care of patients with heart failure
Sadik, A., Yousif, M. A., & McElnay, J. C. (2005) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2005.02387.x · Cited by 124
Gwadry-Sridhar, F. H., Arnold, J. M. O., Zhang, Y., Brown, J. E., Marchiori, G. E., & Guyatt, G. H. (2005) · American Heart Journal · doi:10.1016/j.ahj.2005.08.016 · Cited by 118
Impact of pharmacist interventions on hospital readmissions for heart failure
Rainville, E. C. (1999) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/56.13.1339 · Cited by 97
Underutilisation of ACE inhibitors in patients with congestive heart failure.
Bungard, T. J., McAlister, F. A., Johnson, J. A., & Tsuyuki, R. T. (2001) · Drugs · doi:10.2165/00003495-200161140-00002 · Cited by 73
Self-citationEffect of pharmaceutical care services on outcomes for home care patients with heart failure
Triller, D. M., & Hamilton, R. A. (2007) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp050492 · Cited by 55
Cited by
US Pharmacists' Effect as Team Members on Patient Care: Systematic Review and Meta-Analyses
Chisholm-Burns, M. A., Kim Lee, J., Spivey, C. A., Slack, M., Herrier, R. N., Hall-Lipsy, E., Graff Zivin, J., Abraham, I., Palmer, J., Martin, J. R., et al. (2010) · Medical Care · doi:10.1097/mlr.0b013e3181e57962 · Cited by 809
Gillespie, U., Alassaad, A., Henrohn, D., Garmo, H., Hammarlund-Udenaes, M., Toss, H., Kettis-Lindblad, Å., Melhus, H., & Mörlin, C. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.71 · Cited by 582
American Society of Health-System Pharmacists
(2016) · The SAGE Encyclopedia of Pharmacology and Society · doi:10.4135/9781483349985.n33 · Cited by 510
Atherton, J. J., Sindone, A., De Pasquale, C. G., Driscoll, A., MacDonald, P. S., Hopper, I., Kistler, P. M., Briffa, T., Wong, J., Abhayaratna, W., et al. (2018) · Heart, Lung and Circulation · doi:10.1016/j.hlc.2018.06.1042 · Cited by 431
Santschi, V., Chiolero, A., Colosimo, A. L., Platt, R. W., Taffé, P., Burnier, M., Burnand, B., & Paradis, G. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.113.000718 · Cited by 349
Metadata
- Authors
- Koshman, S. L.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2008-04-14
- Volume
- 168
- Issue
- 7
- Pages
- 687
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W2113761181
- Cited by
- 336
- References
- 21
- FWCI
- 17.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.